Pituitary

Papers
(The TQCC of Pituitary is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours153
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life51
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours50
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies42
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening39
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency38
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas36
The impact of facility type and volume on treatment and overall survival in craniopharyngioma34
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland31
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients29
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey27
Pituitary: hic manebimus optime26
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study26
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre24
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors24
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy23
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly22
Non-written guidelines in pituitary tumor surgery. The hidden curriculum20
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery20
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants20
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study20
Genetic models of Cushing’s disease20
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome18
Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates18
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery18
Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria18
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery18
Pituitary metastases: a case series and scoping review18
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas18
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature17
Consensus on acromegaly complications: an update17
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders17
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience17
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation16
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach16
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors16
Diagnosis of growth hormone deficiency: searching for Consensus along life16
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes16
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)15
TSH-secreting pituitary adenomas and bone14
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions14
Diagnostic performance of desmopressin stimulation test in pediatric cushing’s disease14
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)14
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas14
IGF-1 is positively associated with BMI in patients with acromegaly14
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”14
Cushing’s disease and bone14
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)14
Development and validation of clinical screening systems for Cushing disease in the United States13
Outcomes in surgical management of microprolactinomas: an international multi-institutional series13
The impact of growth hormone (GH) on immunosenescence: exploring the role of B and T cells13
Circadian rhythm proteins as potential biomarkers in pituitary adenomas: an immunohistochemical analysis13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study13
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study13
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly13
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade13
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation13
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition13
Pituitary surgery and COVID13
Is diabetes with acromegaly for life?12
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study12
Long COVID and pituitary dysfunctions: a bidirectional relationship?12
Copeptin after pituitary surgery: is it worth measuring?12
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review12
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort11
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly11
Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort11
Validation and modification of the PANOMEN 3 classification for predicting long-term recurrence/progression and quality of life in patients with pituitary adenomas: a multicentre retrospective cohort 11
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas11
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience11
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort11
Nelson’s syndrome: reappraisal of an uncommon disease10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis10
Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese 10
Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly10
Refractory nonfunctioning pituitary adenomas10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis10
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists9
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes9
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease9
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans9
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis9
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis9
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment9
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon9
Skeletal fragility in pituitary disease: how can we predict fracture risk?9
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma9
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings8
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency8
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?8
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency8
A Retrospective cohort study of Knosp grade reporting of cavernous sinus invasion in pituitary macroadenomas8
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis8
Giant prolactinomas, a detailed analysis of 196 adult cases8
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence8
Pituitary stalk biopsy – A systematic review of the safety and efficacy of stalk lesion biopsy8
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas8
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency7
Correction: consensus on criteria for acromegaly diagnosis and remission7
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants7
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis7
An update on, and genetics of refractory adenomas of childhood7
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma7
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database7
Postoperative weight gain following endoscopic endonasal surgery for craniopharyngiomas in children and adults: A retrospective cohort study7
Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications7
Cushing’s disease: role of preoperative and primary medical therapy7
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis7
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly7
How to manage intolerance to dopamine agonist in patients with prolactinoma7
Cushing’s syndrome: Guidance on thromboprophylaxis at last7
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours7
0.22713279724121